z-logo
open-access-imgOpen Access
Prosthetic joint infection after total hip arthroplasty caused by Sneathia sanguinegens
Author(s) -
Shohei Kawakami,
Ken Iwata,
Masashi Shimamura,
Tasuku Mashiba,
Kyoko Yokota,
Kiyoshi Negayama,
Kiyofumi Ohkusu,
Toshiyuki Yamamoto
Publication year - 2020
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000022494
Subject(s) - medicine , osteoarthritis , surgery , implant , synovial fluid , arthroplasty , debridement (dental) , antibiotic therapy , antibiotics , total hip arthroplasty , abscess , pathology , microbiology and biotechnology , alternative medicine , biology
Sneathia sanguinegens ( S sanguinegens) is a gram-negative rod-shaped bacterium mostly reported to cause a perinatal infection, and there are no reports of S sanguinegens in prosthetic joint infection (PJI). The purpose of this report is to describe a very rare case of PJI after total hip arthroplasty (THA) caused by S sanguinegens . Patient concerns: A 79-year-old woman presented with right coxalgia, inability to walk, and a fever of 39°C. She had undergone THA 28 years earlier for osteoarthritis of the hip. Diagnoses: The diagnosis was acute late-onset PJI, because blood tests revealed marked inflammatory reaction and computed tomography showed an abscess at the right hip joint; synovial fluid analysis resulted in detection of a gram-negative bacillus. Intervention: Surgical debridement with retention of the implant and antibiotic therapy was performed. Outcomes: One month after surgery, polymerase chain reaction (PCR) assay showed that the pathogen was 99.9% likely to be S sanguinegens . There has been no recurrence of infection or loosening of the implant in the 2 years since her surgery. Lessons: PCR should facilitate detection of previously unknown pathogens and potentially novel bacterial species.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here